The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
substantial global morbidity and deaths, leading governments to turn to non-pharmaceutical …

During the coronavirus disease 2019 (COVID-19) pandemic, Singapore implemented
various measures to mitigate the transmission of the severe acute respiratory syndrome …

To face the COVID-19 outbreak, a wide range of non-pharmaceutical interventions (NPIs)
aimed at limiting the spread of the virus in communities, such as mask-wearing, hand …

By the beginning of 2020, infection caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) had rapidly evolved into an emergent worldwide pandemic, an …

Objectives The effect of SARS-CoV-2 on existing respiratory viruses in circulation and the
overall burden of viral respiratory disease remains uncertain. Traditionally, severe viral …

Background Little is known about the relationships between severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), the respiratory virus responsible for the ongoing …

Influenza viruses cause annual epidemics and occasional pandemics of respiratory tract
infections that produce a wide spectrum of clinical disease severity in humans. The novel …

Background There is sufficient epidemiological and biological evidence of increased human
susceptibility to viral pathogens such as Middle East respiratory syndrome coronavirus …

Measures intended to limit the spread of the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) virus at the start of the coronavirus disease 2019 (COVID-19) pandemic …

Objective: This study aimed to examine the effectiveness of containment strategies and
mitigation strategies to provide a reference for controlling the ongoing global spread of the …